← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2001First marketed drug
Dec 8, 2000First NDA
Nov 8, 2001Last known activity
Sep 1, 2013
Acquired by Perrigo on Jan 1, 2013
Timeline
1960s
- Jan 1, 1969
Elan Pharmaceuticals— Founded
1990s
- Jan 1, 1996
Athena Neurosciences— Acquired
- Jan 1, 1998
Carnrick Laboratories— Acquired
- Jan 1, 1998
Neurex— Acquired
2000s
- Jan 1, 2000
Dura Pharmaceuticals— Acquired
- Dec 8, 2000
rimabotulinumtoxinB— Marketing Organization
- Nov 8, 2001
frovatriptan— NDA Organization
2010s
- Jan 1, 2013
Perrigo— Acquired By
Drugs by trial phase (17 distinct, 36 trials)
Phase 4 (6 own, 0 via acquisition)
Phase 3 (3 own, 1 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
- Aggression
- Alzheimer Disease
- Arthritis
- Arthritis, Rheumatoid
- Bipolar Disorder
- Cerebral Palsy
- Chronic Pain
- Crohn Disease
- Dementia
- Disease
- Down Syndrome
- Headache
- Hepatitis
- Hepatitis A
- Hepatitis C
- Hepatitis C, Chronic
- Immune Reconstitution Inflammatory Syndrome
- Leukoencephalopathies
- Leukoencephalopathy, Progressive Multifocal
- Migraine Disorders
- Multiple Sclerosis
- Multiple Sclerosis, Chronic Progressive
- Multiple Sclerosis, Relapsing-Remitting
- Muscle Spasticity
- Pneumonia
- Psychomotor Agitation
- Sclerosis
- Spinal Cord Injuries
- Syndrome
Marketed drugs (4)
Subsidiaries (4 direct, 4 total across the full acquisition tree)
Recent trials (35)
- NCT01791725CollaboratorPhase 2Sep 1, 2013
- NCT01766336CollaboratorPhase 2Jan 1, 2013
- NCT01735630CollaboratorPhase 2Nov 1, 2012
- NCT01674010CollaboratorPhase 2Aug 1, 2012
- NCT01318421Lead sponsorPhase 1Dec 1, 2010
- NCT01211665CollaboratorPhase 4Sep 1, 2010
- NCT01144351Lead sponsorPhase 1Mar 1, 2010
- NCT01058005CollaboratorPhase 3Mar 1, 2010
- NCT01071083CollaboratorPhase 2Mar 1, 2010
- NCT00871780CollaboratorPhase 4Aug 1, 2009
- NCT00746941CollaboratorPhase 1/Phase 2Jan 1, 2009
- NCT00801125CollaboratorPhase 4Dec 1, 2008
- NCT00744679CollaboratorPhase 4Nov 1, 2008
- NCT00559702CollaboratorPhase 1Oct 1, 2007
- NCT00516893CollaboratorPhase 2Oct 1, 2006
Details
- Founded
- Dublin, IE Jan 1, 1969
- First NDA
- Nov 8, 2001
- Last known activity
- Sep 1, 2013
Designations held
- Priority review
Notes
Acquired by Perrigo